UI059

DRUG3 trials

Sponsors

Korea United Pharm. Inc.

Conditions

GERDGastro Esophageal Reflux DisorderGastro-Intestinal Disorder

Phase 1

A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects

CompletedNCT06141577

Korea United Pharm. Inc.GERD

Start: 2023-10-08End: 2023-11-15Updated: 2023-11-21

A Study to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UI059 and UIC202201

Not yet recruitingNCT06393881

Korea United Pharm. Inc.Gastro-Intestinal Disorder

Start: 2024-07-03End: 2024-09-21Target: 66Updated: 2024-05-01

Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy Volunteers

Not yet recruitingNCT07727629

Korea United Pharm. Inc.Gastro Esophageal Reflux Disorder

Start: 2026-07-01End: 2026-08-01Target: 60Updated: 2026-07-27